ArticleClinical and translational medicine2023
Mitochondrial and immune response dysregulation in melanoma recurrence.
Abstract readLetter
In one paragraph
Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Spatial Proteomics as a Potential Decision-Support Layer for Early Melanoma: A Narrative Review.International journal of dermatology · 2026Review
- AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient.NPJ precision oncology · 2026Article
- Article
- Multistage responsive microneedle delivery system loaded oncolytic virus for topical therapy of melanoma.Acta pharmaceutica Sinica. B · 2026Article
- Exploring the immune landscape of melanoma of the lower female genital tract.Virchows Archiv : an international journal of pathology · 2026Article
- Intercellular mitochondrial transfer in melanoma progression and therapeutic resistance: mechanisms and targeting potential.Frontiers in oncology · 2026Review
- Genetic Insight into Expression-Defined Melanoma Subtypes and Network Mechanisms: An in Silico Study.Genes · 2025Article
- Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity.Clinical and translational medicine · 2025Article
- Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.Cancer · 2025Article
- Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium.Molecular & cellular proteomics : MCP · 2024Article
- Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.Clinical and translational medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Leticia SzadaiDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Jéssica de Siqueira GuedesClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Nicole WoldmarClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Natália Pinto de AlmeidaClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Ágnes Judit JánosiDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Ahmad RajehDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ferenc KovácsSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
András KristonSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
Ede MighSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
Guihong WanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Nga NguyenDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Henriett OskolásSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
Roger AppelqvistClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Fábio Cn NogueiraChemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Gilberto B DomontChemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Kun-Hsing YuDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Eugene R SemenovDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Johan MalmSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
Melinda RezeliClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.ORCID 0000-0003-4373-5616
Elisabet WieslanderSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.
David FenyöDepartment of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Grossman School of Medicine, New York, USA.
Lajos KeményDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
Peter HorvathSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
István Balázs NémethDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
György Marko-VargaClinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, Lund, Sweden.
Jeovanis GilSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Lund, Sweden.ORCID 0000-0003-3601-3893
Funding
Robust, Generalizable, and Fair Machine Learning Models for BiomedicineR35GM142879 · NIGMS · HARVARD MEDICAL SCHOOL · PI YU, KUN-HSING · 2021 to 2025
$2.4MMitigating Hematologic Adverse Events in Patients with Myeloid Malignancies: A Novel Causal Artificial Intelligence ApproachR01HL174679 · NHLBI · HARVARD MEDICAL SCHOOL · PI Kun-Hsing Yu · 2024 to 2026
$2.3MExplainable Artificial Intelligence for Melanoma Recurrence Prediction via Integrative Modeling of Multiplexed Imaging with Transcriptomics and HistopathologyK99CA286966 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WAN, GUIHONG · 2024 to 2025
$352kNCI NIH HHS K99 CA286966NHLBI NIH HHS R01 HL174679NIGMS NIH HHS R35 GM142879NIGMS NIH HHS R35GM142879
Abstract
PubMed holds no abstract for this paper.
Indexed as
MelanomaHumansImmunityMitochondria
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.